drugset / Trial / NCT01846468
An Ascending Dose Study to Assess Safety, Tolerability, PK/PD of LHW090 in Healthy Volunteers and in Subjects With Renal Dysfunction
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of the study is to provide pertinent information to enable decisions regarding the developability of LHW090 for use in patients with chronic renal insufficiency, including a comparison of the potential risk-benefit ratio of several doses of the study drug to enable optimal doses to be tested in later studies.
Timeline
- Start
- 2013-03-01
- Primary completion
- 2014-06-28
- Completion
- 2014-06-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LHW090 | Unknown | 1 mg | — |
| Subject | LHW090 | Unknown | 12.5 mg | — |
| Subject | LHW090 | Unknown | 100 mg | — |